Dextromethorphan Hydrobromide + Phenylephrine Hydrochloride + Cetirizine HydrochlorideThird Party Manufacturing in India

Dextromethorphan Hydrobromide works by depressing the cough center in the medulla oblongata, which helps reduce the urge to cough. Phenylephrine Hydrochloride is a selective alpha-1 adrenergic receptor agonist. It stimulates these receptors in the nasal mucosa, leading to vasoconstriction. This biological effect helps the body reduce tissue swelling and nasal congestion, opening up the airways. Cetirizine Hydrochloride is a second-generation H1 histamine receptor antagonist. It blocks the action of histamine, a natural substance produced during allergic reactions.

By combining these three active ingredients, the formulation provides comprehensive relief from multiple respiratory symptoms. Dextromethorphan controls the dry cough, Phenylephrine clears the blocked nose, and Cetirizine tackles allergic symptoms like runny nose, sneezing, and watery eyes. Unlike older antihistamine combinations, this specific formulation leverages Cetirizine's non-sedating properties, resulting in a medication that is highly effective while being well-tolerated for daily use.

Therapeutic Uses

Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Cetirizine Hydrochloride in combination are prescribed for the treatment of:

• Dry Cough (Non-productive cough): Effectively suppresses the cough reflex in the brain, providing relief from persistent, irritating dry coughs.
• Nasal Congestion: Relieves stuffiness and blocked nose associated with common colds, sinusitis, and upper respiratory tract infections.
• Allergic Rhinitis: Treats symptoms like runny nose, sneezing, itchy or watery eyes, and itchy throat caused by seasonal or perennial allergies.
• Common Cold Symptoms: Provides symptomatic relief from the multifaceted discomforts of viral upper respiratory infections.

Why Manufacturers Choose This Combination

The combination of an antitussive, a decongestant, and a non-sedating antihistamine represents a highly optimized formulation for the OTC and prescription respiratory markets. By utilizing Cetirizine instead of older, highly sedating alternatives like Chlorpheniramine, this liquid formulation offers a modern, patient-friendly approach to cough and cold management.

This makes the Dextromethorphan, Phenylephrine, and Cetirizine combination one of the most sought-after cough syrups for third party manufacturing in India, with consistent demand from PCD franchise operators and pediatric segments. It is highly valued for its comprehensive symptom coverage and improved patient compliance, ensuring strong market performance during seasonal cold and flu peaks.